Departamento de Química, Universidad de Los Andes, Carrera 1 No. 18A-12, 111711, Bogotá, Colombia.
Human Genetics Laboratory, Universidad de Los Andes, Carrera 1 No. 18A-12, 111711, Bogotá, Colombia.
Biometals. 2021 Feb;34(1):119-140. doi: 10.1007/s10534-020-00268-8. Epub 2020 Nov 13.
The synthesis of eight novel Zn(II), Co(II), Cu(II), Ni(II) and Pt(II) complexes (2-9) derived from the ONNO tetradentate coumarin Schiff-Base donor ligands, L and the novel L, was performed. All compounds were characterized by analytical, spectrometry and spectroscopy techniques. Complexes 2-4 were also characterized by DFT calculations and the structures of 5 and 6 were determined by single-crystal X-ray diffraction analysis. A cytotoxicity study was carried out through an MTT assay in the carcinogenic cell line HeLa and the noncarcinogenic cell lines HFF-1 and HaCaT. The results indicated that among all the evaluated compounds, 2 and 6 presented the best anticarcinogenic potential against HeLa cells with an IC of 3.5 and 4.1 µM, respectively. In addition, classical molecular dynamics simulations were performed on the synthesized coordination compounds bound to G4 DNA architectures in the scope of shedding light on their inhibition mode and the most conserved interactions that may lead to the biological activity of the compounds.
合成了 8 种新型 Zn(II)、Co(II)、Cu(II)、Ni(II) 和 Pt(II) 配合物(2-9),这些配合物是由 ONNO 四齿香豆素席夫碱给体配体 L 和新型 L 衍生而来。所有化合物均通过分析、光谱和光谱技术进行了表征。配合物 2-4 还通过 DFT 计算进行了表征,5 和 6 的结构通过单晶 X 射线衍射分析确定。通过 MTT 测定法在致癌细胞系 HeLa 和非致癌细胞系 HFF-1 和 HaCaT 中进行了细胞毒性研究。结果表明,在所评估的化合物中,2 和 6 对 HeLa 细胞表现出最好的抗癌潜力,IC 分别为 3.5 和 4.1µM。此外,还对合成的配位化合物与 G4 DNA 结构进行了经典分子动力学模拟,以阐明它们的抑制模式和可能导致化合物生物活性的最保守相互作用。